The PRECEDE Consortium is an observational longitudinal prospective cohort study to change the survival rate of pancreatic cancer through early detection!
#WorldCancerDay2022 So incredibly grateful to all our collaborators in early detection for pancreatic cancer! Special thanks to @katebolduan and our amazing patients for sharing their stories! We have a lot of work to do!! #earlydetectionpancreaticcancer
https://t.co/SK9ANucTBn
#Thanksgiving gatherings could be the right time to start a conversation about the importance of testing for #pancreaticcancer with your family. 💜🦃 Two genetic counselors give you some tips on how to make it a useful, productive discussion: https://t.co/3IUopSj85P
So sad to hear about this! Our hearts go out to Willie’s family and loved ones. Early detection is so important before we lose another star to pancreatic cancer! #earlydetection#precedestudy#precedeconsortium
https://t.co/mrkmWAgq86
KMPM announces a new name to reflect their focus on integrated diagnostics for multi-modal and multi-omics data! So excited to be collaborating on this whole new realm of possibilities! #earlydetection#precedeconsortium#precedestudy
https://t.co/VXLN2ZtDkL